High Initial fractional inspired oxygen May Reduce Mortality in Preterm Infants, reveals study
Researchers have found that resuscitation with higher fractional inspired oxygen (FiO2) levels significantly reduces mortality in preterm infants born at less than 32 weeks' gestation. This conclusion emerges from a comprehensive network meta-analysis (NMA) of individual participant data (IPD) from multiple randomized clinical trials. This study was recently published in JAMA Pediatrics by James X. and colleagues.
While the benefits of lower FiO2 levels in term and near-term infants are well-documented, their impact on very preterm infants has been unclear. This study aims to evaluate the relative effectiveness of different initial FiO2 levels in reducing mortality, severe morbidities, and achieving optimal oxygen saturations (SpO2) in infants born before 32 weeks' gestation.
The analysis included data from MEDLINE, Embase, CENTRAL, CINAHL, ClinicalTrials.gov, and WHO ICTRP, spanning from 1980 to October 10, 2023. Eligible studies were randomized clinical trials involving infants born at less than 32 weeks’ gestation. These trials compared at least two different initial oxygen concentrations for delivery room resuscitation, categorized as low (≤0.3), intermediate (0.5-0.65), or high (≥0.90) FiO2. Investigators from eligible studies were invited to contribute their IPD. The data were meticulously processed and verified for quality and integrity. A one-stage contrast-based Bayesian IPD-NMA was conducted using noninformative priors and random effects, adjusted for key covariates.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.